Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review
<p dir="ltr">Sickle cell disease (SCD) is a genetic disease influenced by ethnicity and regional differences in its clinical course. Recent advances in the management of SCD with newer therapies are being introduced to the Western population. However, many of these treatments are yet...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , , , |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513564723642368 |
|---|---|
| author | Fateen Ata (14153304) |
| author2 | Alaa Rahhal (14150403) Lujain Malkawi (15468194) Phool Iqbal (12217770) Ibrahim Khamees (14153301) Mousa A. AlHiyari (12217773) Zohaib Yousaf (14152950) Hanan Qasim (12010314) Awni Alshurafa (15468195) Sundus Sardar (14571097) Saad Javed (5171162) Liam Fernyhough (14151612) Mohamed Yassin (4166515) |
| author2_role | author author author author author author author author author author author author |
| author_facet | Fateen Ata (14153304) Alaa Rahhal (14150403) Lujain Malkawi (15468194) Phool Iqbal (12217770) Ibrahim Khamees (14153301) Mousa A. AlHiyari (12217773) Zohaib Yousaf (14152950) Hanan Qasim (12010314) Awni Alshurafa (15468195) Sundus Sardar (14571097) Saad Javed (5171162) Liam Fernyhough (14151612) Mohamed Yassin (4166515) |
| author_role | author |
| dc.creator.none.fl_str_mv | Fateen Ata (14153304) Alaa Rahhal (14150403) Lujain Malkawi (15468194) Phool Iqbal (12217770) Ibrahim Khamees (14153301) Mousa A. AlHiyari (12217773) Zohaib Yousaf (14152950) Hanan Qasim (12010314) Awni Alshurafa (15468195) Sundus Sardar (14571097) Saad Javed (5171162) Liam Fernyhough (14151612) Mohamed Yassin (4166515) |
| dc.date.none.fl_str_mv | 2023-02-21T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.2147/PGPM.S391394 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Genotypic_and_Phenotypic_Composition_of_Sickle_Cell_Disease_in_the_Arab_Population_-_A_Systematic_Review/22820006 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biological sciences Genetics Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences sickle cell disease genotypes SCD sickle cell anemia Arab |
| dc.title.none.fl_str_mv | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Sickle cell disease (SCD) is a genetic disease influenced by ethnicity and regional differences in its clinical course. Recent advances in the management of SCD with newer therapies are being introduced to the Western population. However, many of these treatments are yet to be used in the Arabic SCD population. Understanding the genetic variations of SCD regionally is essential to anticipate the utilization of new treatments. This systematic review’s main objective is to pool the available data on the genetic composition of SCD in the Arabic population. Data for 44,034 patients was extracted from 184 studies (11 case reports, 8 case series, 56 retrospectives, 107 prospective observational studies, and 2 clinical trials) using PubMed, Scopus, and Google Scholar. Male (49%) and female (51%) patients were equally reported wherever gender was available (N=13105). Various SCD genotypes were reported in a total of 14,257 patients, including Hb SS (77%) Hb Sβ0 (9.9%), and Hb Sβ+ (7.2%), while the rest of the genotypes, including HbSC, HbSD, HbSE, HbSO Arab, Hb S/α-Thal, Hb Sβ0 + α-Thal, and HBS Oman were individually reported in <4% of the cases. Major SCD complications in the Arab population included pain crises (48.25%) followed by neurological complications (33.46%), hepatobiliary complications (25.53%), musculoskeletal complications (24.73%), and hemolytic anemia (23.57%). The treatments reported for SCD included hydroxyurea (20%), blood transfusion (14.32%), and Deferasirox (3.03%). We did not find the use of stem cell transplantation or newer treatments such as L-Glutamine, Voxelotor, Crizanlizumab, or gene therapy reported in any of the studies included in our review. This review highlights the genetic makeup of SCD in Arab countries and its common phenotypic manifestations and will help direct further research on SCD in this region, especially concerning genetic therapy.</p><h2>Other information</h2><p dir="ltr">Published in: Pharmacogenomics and Personalized Medicine<br>License:<a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/<br></a>See article on publisher'swebsite:<a href="http://dx.doi.org/10.2147/PGPM.S391394" target="_blank">http://dx.doi.org/10.2147/PGPM.S391394</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_463bfd07eed92d86efaf5612b3eca7b3 |
| identifier_str_mv | 10.2147/PGPM.S391394 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/22820006 |
| publishDate | 2023 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic ReviewFateen Ata (14153304)Alaa Rahhal (14150403)Lujain Malkawi (15468194)Phool Iqbal (12217770)Ibrahim Khamees (14153301)Mousa A. AlHiyari (12217773)Zohaib Yousaf (14152950)Hanan Qasim (12010314)Awni Alshurafa (15468195)Sundus Sardar (14571097)Saad Javed (5171162)Liam Fernyhough (14151612)Mohamed Yassin (4166515)Biological sciencesGeneticsBiomedical and clinical sciencesCardiovascular medicine and haematologyPharmacology and pharmaceutical sciencessickle cell diseasegenotypesSCDsickle cell anemiaArab<p dir="ltr">Sickle cell disease (SCD) is a genetic disease influenced by ethnicity and regional differences in its clinical course. Recent advances in the management of SCD with newer therapies are being introduced to the Western population. However, many of these treatments are yet to be used in the Arabic SCD population. Understanding the genetic variations of SCD regionally is essential to anticipate the utilization of new treatments. This systematic review’s main objective is to pool the available data on the genetic composition of SCD in the Arabic population. Data for 44,034 patients was extracted from 184 studies (11 case reports, 8 case series, 56 retrospectives, 107 prospective observational studies, and 2 clinical trials) using PubMed, Scopus, and Google Scholar. Male (49%) and female (51%) patients were equally reported wherever gender was available (N=13105). Various SCD genotypes were reported in a total of 14,257 patients, including Hb SS (77%) Hb Sβ0 (9.9%), and Hb Sβ+ (7.2%), while the rest of the genotypes, including HbSC, HbSD, HbSE, HbSO Arab, Hb S/α-Thal, Hb Sβ0 + α-Thal, and HBS Oman were individually reported in <4% of the cases. Major SCD complications in the Arab population included pain crises (48.25%) followed by neurological complications (33.46%), hepatobiliary complications (25.53%), musculoskeletal complications (24.73%), and hemolytic anemia (23.57%). The treatments reported for SCD included hydroxyurea (20%), blood transfusion (14.32%), and Deferasirox (3.03%). We did not find the use of stem cell transplantation or newer treatments such as L-Glutamine, Voxelotor, Crizanlizumab, or gene therapy reported in any of the studies included in our review. This review highlights the genetic makeup of SCD in Arab countries and its common phenotypic manifestations and will help direct further research on SCD in this region, especially concerning genetic therapy.</p><h2>Other information</h2><p dir="ltr">Published in: Pharmacogenomics and Personalized Medicine<br>License:<a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/<br></a>See article on publisher'swebsite:<a href="http://dx.doi.org/10.2147/PGPM.S391394" target="_blank">http://dx.doi.org/10.2147/PGPM.S391394</a></p>2023-02-21T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.2147/PGPM.S391394https://figshare.com/articles/journal_contribution/Genotypic_and_Phenotypic_Composition_of_Sickle_Cell_Disease_in_the_Arab_Population_-_A_Systematic_Review/22820006CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/228200062023-02-21T00:00:00Z |
| spellingShingle | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review Fateen Ata (14153304) Biological sciences Genetics Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences sickle cell disease genotypes SCD sickle cell anemia Arab |
| status_str | publishedVersion |
| title | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review |
| title_full | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review |
| title_fullStr | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review |
| title_full_unstemmed | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review |
| title_short | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review |
| title_sort | Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review |
| topic | Biological sciences Genetics Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences sickle cell disease genotypes SCD sickle cell anemia Arab |